Abnormal pulsatile secretion of growth hormone in non-insulin-dependent diabetes mellitus

Clinical Endocrinology

Volumn 47, Issue 4, 1997, Pages 471-478

  Franek, E ^a   Schaefer, F ^a,c   Bergis, K ^b   Feneberg, R ^a   Ritz, E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Diabetes Klinik   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; GLUCOSE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; PULSATILE FLOW;

EID: 0030882470     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.2901107.x     Document Type: Article

References (38)

1. Albertsson-Wikland, K. & Rosberg, S. (1992) Reproducibility of 24h-growth hormone profiles in children. Acta Endocrinologica, 126, 109-112.
2. Asplin, C.M., Faria, A.C.S., Carlsen, E.C., Vaccaro, V.A., Barr, R.E., Iranmesh, A., Lee, M.M., Veldhuis, J.D. & Evans, W.S. (1989) Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 69, 239-245.
3. Barnes, A.J., Kohner, E.M., Johnston, D.G., Alberti, K.G.M.M. (1985) Severe retinopathy and mild carbohydrate intolerance: Possible role of insulin deficiency and elevated circulating growth hormone. The Lancet, i, 1465-1468.
4. Bjorntorp, P. (1995) Endocrine abnormalities of obesity. Metabolism, 44,21-23.
5. Bolli, G.B. &Gerich, J.E. (1984) The 'dawn phenomenon' - a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. New England Journal of Medicine, 310, 746-750.
6. Casanueva, F.F., Villanueva, L., Dieguez, C., Diaz, Y., Cabranes, J.A., Szoke, B., Scanlon, M.F., Schally, A.V. & Fernandez-Cruz, A. (1987) Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. Journal of Clinical Endocrinology and Metabolism, 65, 634-642.
7. van Cauter, E., Kerkhofs, M., Caufriez, A., van Onderbergen, A., Thorner, M.O. & Copinschi, G. (1992) A quantitative estimation of growth hormone secretion in normal man: Reproducibility and relation to sleep and time of day. Journal of Clinical Endocrinology and Metabolism, 74, 1441-1450.
8. Chapman, I.M., Hartman, M.L., Straume, M., Johnson, M.L., Veldhuis, J.D. & Thorner, M.O. (1994) Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. Journal of Clinical Endocrinology and Metabolism, 78, 1312-1319.
9. De Marinis, L., Mancini, A., Zuppi, P., Calabro, F., Fiumara, C., Lagonigro, G., Fabrizi, M.L. & Sammartano, L. (1992) Influence of pyridostigmine in growth hormone (GH) response to GH-releasing hormone pre- and postprandially in normal and obese subjects. Journal of Clinical Endocrinology and Metabolism, 74, 1253-1257.
10. Flyvbjerg, A., Marshall, S.M., Frystyk, J., Hansen, K.W., Harris, A.G. & Orskov, H. (1992) Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion. Kidney International, 41, 805-812.
11. Friend, K., Iranmesh, A. & Veldhuis, J.D. (1996) The orderliness of the growth hormone (GH) release process and the mean mass of GH secreted per burst are highly conserved in individual men on successive days. Journal of Clinical Endocrinology and Metabolism, 81, 3746-3753.
12. Giustina, A., Bossoni, S., Cimino, A., Pizzocolo, P., Romanelli, G. & Wehrenberg, W.B. (1990) Impaired growth hormone (GH) response to pyridostigmine in type 1 diabetic patients with exaggerated GH releasing hormone stimulated GH secretion. Journal of Clinical Endocrinology and Metabolism, 71, 1486-1490.
13. Giustina, A., Bresciani, E., Tassi, C., Girelli, A. & Valentini, U. (1994) Effect of pyridostigmine on the growth hormone response to growth hormone-releasing hormone in lean and obese type II diabetic patients. Metabolism, 43, 893-898.
14. Giustina, A. & Wehrenberg, W.B. (1994) Growth hormone neuroregulation in diabetes mellitus. Trends in Endocrinology and Metabolism, 5, 73-78.
15. Hansen, A.P. (1973) Abnormal serum growth hormone response to exercise in maturity-onset diabetics. Diabetes, 22, 619-628.
16. Iranmanesh, A., Lizarralde, G. & Veldhuis, J.D. (1991) Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. Journal of Clinical Endocrinology and Metabolism, 73, 1081-1088.
17. Iranmesh, A., Grisso, B. & Veldhuis, J.D. (1994) Low basal and persistent pulsatile growth hormone secretion are revealed in normal and hyposomatotropic men studied with a new ultrasensitive chemiluminscence assay. Journal of Clinical Endocrinology and Metabolism, 78, 526-535.
18. Johnson, M.L. & Faunt, L.M. (1992) Parameter estimation by least-squares methods. Methods in Enzymology, 210, 1-37.
19. Kjeldsen, H., Hansen, A.P. & Lundbaeck, K. (1975) Twenty-four-hour serum growth hormone levels in maturity-onset diabetics. Diabetes, 24, 977-982.
20. Kopelman, P.G., Mason, A.C., Noonan, K. & Monson, J.P. (1984) Impaired growth hormone responses to growth hormone releasing factor in diabetic men. Clinical Endocrinology, 28, 33-38.
21. Lee, E.J., Kim, K.R., Lee, K.M., Lim, S.K., Lee, H.C., Lee, J.H. & Lee, D.J. (1994) Reduced growth hormone response to 1-dopa and pyridostigmine in obesity. International Journal of Obesity Related Metabolic Disorders, 18, 465-468.
22. Lee, E.J., Nam, S.Y., Kim, K.R., Lee, H.C., Cho, J.H., Nam, M.S., Song, Y.D., Lim, S.K. & Huh, K.B. (1995) Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects. Journal of Clinical Endocrinology and Metabolism, 80, 2495-2498.
23. Masuda, A., Shibasaki, T., Nakahara, M., Imaki, T., Kiyosawa, Y., Jibiki, K., Demura, H., Shizume, K. & Ling, N. (1985) The effect of glucose on growth hormone (GH) -releasing hormone-mediated GH secretion in man. Journal of Clinical Endocrinology and Metabolism, 60, 523-526.
24. Miller, J.D., Wright, N.M., Lester, S.E., Felsing, N.E., Linzer, J., Chan, E., White, D.A. & Charles, M.A. (1992) Spontaneous and stimulated growth hormone release in adolescents with type I diabetes mellitus: effects of metabolic control. Journal of Clinical Endocrinology and Metabolism, 75, 1087-1091.
25. Nieves-Rivera, F., Rogol, A.D., Veldhuis, J.D., Branscom, O.K., Martha, P.M. Jr, & Clarke, W.L. (1993) Alterations in growth hormone secretion and clearance in adolescent boys with insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 77, 638-643.
26. Owens, D.R., Volund, A., Jones, D., Shannon, J.D., Jones, I.R., Birtwell, A.J., Luzio, S., Williams, S., Dolben, J. & Creagh, F.N. (1988) Retinopathy in newly presenting non-insulin-dependent (type 2) diabetic patients. Diabetes Research, 9, 59-65.
27. Pal, B.R., Matthews, D.R., Edge, J.A., Mullis, P.E., Hindmarsh, P.C. & Dunger, D.B. (1993) The frequency and amplitude of growth hormone secretory episodes as determined by deconvolution analysis are increased in adolescents with insulin-dependent diabetes mellitus and are unaffected by short-term euglycemia. Clinical Endocrinology, 38, 93-100.
28. Perriello, G., De Feo, P., Torlone, E., Fanelli, C., Santeusanio, F., Brunetti, P. & Bolli, G.B. (1990) Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extra-hepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia, 33, 52-59.
29. Press, M., Tamborlane, W.V. & Sherwin, R.S. (1984a) Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes. New England Journal of Medicine, 310, 810-815.
30. Press, M., Tamborlane, W.V., Thorner, M.O., Vale, W., Rivier, J., Gertner, J.M. & Sherwin, R.S. (1984b) Pituitary response to growth hormone-releasing factor in diabetes: failure of glucose-mediated suppression. Diabetes, 33, 804-806.
31. Richards, N.T., Wood, S.M., Christofides, N.D., Bhuttacharji, S.C. & Bloom, S.R. (1984) Impaired growth hormone response to human pancreatic growth hormone releasing factor (GRF (1-44) ) in type 2 (non-insulin-dependent) diabetes. Diabetologia, 27, 529-534.
32. Schaefer, F., Daschner, M., Veldhuis, J.D., Oh, J., Qadri, F. & Schaerer, K. (1994) In vivo alterations in the gonadotropin-releasing hormone pulse generator and the secretion and clearance of luteinizing hormone in the castrate uremic rat. Neuroendocrinology, 59, 285-296.
33. Shaper, N.C. (1990) Growth hormone secretion in type 1 diabetes: A review. Acta Endocrinologia, 122, 7-12.
34. Ulloa-Aguirre, A., Blizzard, R.M., Garcia-Rubi, E., Rogol, A.D., Link, K., Christie, C.M., Jonson, M.L. & Verldhuis, J.D. (1990) Testosterone and oxandrolone, a non-aromatizable androgen, specifically amplify the mass and rate of growth hormone secreted per burst without altering GH secretory burst duration or frequency or the GH half-life. Journal of Clinical Endocrinology and Metabolism, 71, 846-854.
35. Veldhuis, J.D., Carlson, M.L. & Johnson, M.L. (1987) The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. Proceedings of the National Academy of Sciences of the United States of America, 84, 7686-7690.
36. Veldhuis, J.D., Liem, A.Y., South, S., Weltman, A., Weltman, J., Clemmons, D.A., Abbott, R., Mulligan, T., Johnson, M.L., Pincus, S e. a. (1995) Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. Journal of Clinical Endocrinology and Metabolism, 80, 3209-3222.
37. Wright, A.D., Kohner, E.M., Oakley, N.W., Hartog, M., Joplin, G.F. & Fraser, T.M. (1969) Serum GH levels and response of diabetic retinopathy to pituitary ablation. British Medical Journal, ii, 343-348.
38. Würzburger, M.I., Prelevic, G., Sönksen, P.H., Prelic, L.A., Till, S. & Morris, R.W. (1990) The effect of improved blood glucose on growth hormone and cortisol secretion in insulin-dependent diabetes. Clinical Endocrinology. 32, 787-797.